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Abstract – Burkholderia pseudomallei are Gram negative highly pathogenic bacteria of humans and 
animals causing a multisystemic disease called melioidosis. They have recently gained a lot of interest 
from the research community and public health organisations because of their great potential to be 
used as an agent of bioterrorism. This has made the search for simple, rapid, accurate and the most 
definitive means of their detection, identification and discrimination very critical and necessary. This 
article aimed to review the molecular techniques used for detection, identification and differentiation 
of B. pseudomallei. Although, culture and isolation techniques maintained their usefulness in 
confirming cases of melioidosis, their time limitation (can take up to a week for confirming diagnosis) 
leads to the search for rapid and simple techniques. Consequently, serology-based tests have been 
developed which are both faster and less sophisticated. However, the presence of high background 
titre levels and cross-reaction with other organisms make it less reliable. Thus, efforts have been 
directed to explore rapid and accurate molecular techniques and resulting in the development and 
validation of various PCR-based identification techniques targeting either single or multiple genes. 
Although requiring some level of instrumentation and expertise, PCR-based techniques have been 
reported to be very useful in diagnosis of melioidosis. We recommend the 16S rRNA PCR (especially 
augmented with other molecular methods such as gene sequencing and analysis) and MLST 
techniques for timely detection, identification and differentiation of B. pseudomallei for routine 
diagnosis and epidemiological studies respectively. 
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Introduction 
Burkholderia pseudomallei,  aerobic, Gram negative, rod-shaped motile bacteria with irregular bipolar 
‘safety pin’ appearance, are causative agents of melioidosis, a multisystemic, often fatal disease of 
animals and humans. This disease is endemic primarily in Thailand and northern Australia, but 
reported sporadically in most parts of the world (Gilad, Harary, Dushnitsky, Schwartz, & Amsalem, 
2007; Brett & Woods, 2000). This bacterium was first described in 1912 by Alfred Whitmore and C. 
S. Krishnaswami as Bacillus pseudomallei due to its remarkable similarity to the causative agent of 
‘Glanders’, Bacillus mallei (its name as of then) (Lazar et al., 2009). Subsequent studies by Haynes in 
1957 led to its reclassification and moving to the genus Pseudomonas and recent work by Tyler et al. 
1995; Li & Hayward 1994 and Yabuuchi et al., 1992 necessitate its reclassification to a new genus 
Burkholderia (the name was assigned to honour W.H. Burkholder, a bacteriologist who first described 
Burkholderia cepacia-a plant pathogen causing skin rot disease of onion (Burkholder, 1950).  
 
The development and application of molecular-based detection and differentiation methods have 
revolutionized diagnostic and environmental testing of microorganism and are becoming popular 
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nowadays partly due to their sensitivity, accuracy and rapidity compared to routine culture-based 
isolation and identification and/or serological techniques. Advanced molecular characterisation has 
revealed that B. pseudomallei, B. mallei (etiologic agent of Glanders) and B. thailandensis (avirulent 
B. pseudomallei) are phylogenetically very close and show a high degree of similarities between their 
phenotypic and genotypic properties. The significance of the etiologic agents of aforementioned 
diseases, with regards to their clinical presentations and potential use as bioweapons, as well as their 
remarkable phenotypic and genomic similarities have promoted the creation of several molecular-
based assays that specifically detect and differentiate B. pseudomallei with other closely related 
biotypes. This includes (but not limited to) the following: 
 
PCR-based methods 
PCR-based molecular characterization of B. pseudomallei is widely used as a method of identification 
and confirmation of the pathogen as culture-based methods are time-consuming and may lead to 
misidentification (Ashdown, 1979). Most of these techniques are designed to amplify portion(s) of the 
genome with housekeeping functions using set(s) of oligonucleotide primers. Some PCR techniques 
were developed for laboratory diagnostic purposes while others are best suited for comparative 
genomics and phylogenetic analysis studies in epidemiological research. The choice of PCR method 
to be employed mostly relies on the purpose of the study. For clinical identification alone, a 
conventional gel PCR is usually employed to amplify certain genes such as 16s rRNA, 23s rRNA, 
fliC gene etc. with or without sequencing the gene amplified. However, for epidemiological studies 
(involving the study of clonality, comparative genomics, evolutional relatedness, tracing ancestral 
origin, etc.), further manipulation of DNA is required, such as restriction digest, Southern blots, 
sequencing etc. to suit these applications.  
 
Single or multiple gene analysis 
For B. pseudomallei detection, various PCR assays of this kind have been developed, validated and 
successfully used to amplify the gene for the 16s rRNA (Brook, Currie, & Desmarchelier, 1997) 
(Dharakul et al., 1996 & 1999), the orf2 gene of TTS1gene cluster (Winstanley & Hart, 2000), serine 
metalloprotease (mprA) (Neubauer et al., 2007), polyhydroxyalkanoate synthase gene (phaC) (Merritt, 
Inglis, Chidlow, & Harnett, 2006), flagella structural protein fliC (Wajanarogana, Sonthayanon, 
Simpson, Tungpradabkul, & Panyini, 1999), repetitive element (Liu, Wang, Ã, Yap, & Lee, 2002) and  
lots more. An array of PCR-based methodologies used in molecular characterization of B. 
pseudomallei is discussed below 
 
16S rRNA 
Various PCR techniques have been developed targeting the gene for the 16S rRNA for detection and 
differentiation of B. pseudomallei with other closely related species and biotypes. The initial work by 
Brook et al., (1997) documented a sensitivity of more than ten times than that of culture method and 
100% accuracy when using DNA from the bacterial culture. However, sensitivity and specificity drop 
tremendously when using environmental samples such as soil (as a source of DNA) to 75% and 59.4% 
respectively. These findings make this technique unsuitable for environmental studies due to its low 
accuracy. The following five years, two qPCR were developed based on TaqMan probes and SYBR 
green and evaluated using more than 80 B. pseudomallei isolates (Yap, Ang, Seah, & Phang, 2002). 
 
Other PCR methods targeting the 16s rRNA which have been developed and evaluated in B. 
pseudomallei detection and differentiation include that of Dharakul et al., (1996) which reported 100% 
accuracy. In this study, various clinical samples were evaluated to explore their ability to detect B. 
pseudomallei from septicaemia patients. A follow-up study of this procedure reported 100% 
specificity and sensitivity on buffy coat samples (Haase et al., 1998). Another follow- up clinical 
study reported inconsistent diagnostic PCR accuracy of less than 55% on plasma samples (Kunakorn, 
Raksakait, Sethaudom, Sermswan, & Dharakul, 2000). The low diagnostic sensitivity of Dharakul et 
al's assay on one of the two clinical follow-up studies could be attributed to differences in sample 
types (The higher diagnostic accuracy came from the follow-up study evaluating buffy coat and the 
lower diagnostic accuracy from the follow-up study evaluating plasma samples) because the same 
plasma samples were evaluated using another PCR test in which Dharakul et al's assay turned to have 
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the highest relative sensitivity (Rattanathongkom, Sermswan, & Wongratanacheewin, 1997). 
Similarly, the follow-up study on inoculated buffy coat samples showed 100 times more sensitive in 
detecting B. pseudomallei and B. mallei than a previously described 23s rRNA method (Lew and 
Desmarchelier, 1994).  
 
Similarly, in 1999, the same author (Dharakul) developed a multiplex PCR method targeting 16s 
rRNA variable region to differentiate B. pseudomallei from B. mallei, B. thailandensis and other 
species of Burkholderia. The technique was valuated on inoculated soil samples (Chen, Lin, Pan, 
Chien, & Chen, 2002) clinical buffy coat samples (Winstanley & Hart, 2000) and both studies 
reported 100% environmental and clinical accuracies respectively. This procedure appears to be 
relatively the best for differentiation of these species using purified DNA and clinical buffy coat 
samples.  
 
Flagellar structural protein (fliC) 
Wajanarogana et al., (1999) developed a PCR assay targeting a variable domain of the flagellar 
structural protein (fliC) to differentiate B. pseudomallei and B. thailandensis. The method had 100% 
accuracy. Several studies have evaluated these protocol using both clinical and environmental samples 
(Chen et al., 2002; Kao, Chen, Chen, Lin, & Chen, 2003; Sonthayanon, Krasao, Wuthiekanun, 
Panyim, & Tungpradabkul, 2002). Using the same samples, the method was also evaluated and 
compared with additional PCR methods (Dharakul et al., 1999; Winstanley & Hart, 2000) and the 
findings indicated that Wajanarogana et al's and Dharakul et al's methods were superior to culture in 
detecting B. pseudomallei in soil samples, indicating PCR sensitivity beyond culture (Chen, Lin, et al., 
2010). This protocol was shown to be very useful in differentiating B. pseudomallei from B. 
thailandensis in the environment using soil and water samples. 
 
16s rRNA and flagellar filament structural protein (fliC) 
PCR assays have been developed targeting other genes in addition to 16s rRNA. Two of such 
procedures were developed to simultaneously amplify the 16s rRNA and the flagellar filament 
structural protein (fliC) genes for better detection and differentiation of B. pseudomallei from other 
close biotypes (Chantratita et al., 2007; Tomaso et al., 2004). The two procedures performed well on 
purified DNA, crude bacterial lysates and blood samples with 100% accuracy. Similarly, follow-up 
studies by Hagen et al., (2002) and Tomaso et al., (2005) reported consistent high accuracy. 
 
23s rRNA 
In 1994, Lew and Desmarchelier 1994 developed a PCR method targeting the 23s rRNA, which was 
reported to have 100% accuracy in identifying and differentiating B. pseudomallei from B. mallei 
using purified DNA from the bacterial culture. Although Lew and Desmarchelier 1994 method 
showed 100% clinical accuracy, subsequently, three series of follow-up studies indicated a low 
accuracy when using bacterial lysate and buffy coat samples and one of them detected B. cepacia 
strains, and therefore had a PCR accuracy less than 100% (Brook et al., 1997; Haase et al., 1998). 
This 23s rRNA method needs further evaluation due to its low sensitivity and specificity in samples 
other than purified DNA from bacterial culture and detection of B. cepacia respectively. Therefore, 
more recent and better evaluated B. pseudomallei differentiation tests are preferable. 
 
Subsequently, two novel 23s rRNA PCR assays have been developed by Tkachenko et al., (2003) to 
detect and differentiate B. pseudomallei from B. mallei. This study followed the same pattern as that 
of Lew and Desmachelier 1994 in that, though it was clinically evaluated to be accurate, a follow-up 
study by Antonov et al., (2004) detected B. cepacia using same procedure, indicating a decrease in its 
detection sensitivity. 
 
16-23s rRNA internal transcribed spacers (16-23s rRNA ITS) 
Other assays developed included PCR protocol using primers targeting the 16-23s rRNA internal 
transcribed spacers (ITS) for detecting and differentiating B. pseudomallei (Kunakorn & Markham, 
1995). A series of follow-up studies using the same primer sequences specified in the 16-23s rRNA 
ITS assay and two of which using semi-nested method, reported an accuracy approaching 100% 
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(Inglis, Merritt, Chidlow, Aravena-Roman, & Harnett, 2005; Merritt et al., 2006). The remaining 
follow-up studies using the non-nested procedure reported accuracies of 100% (Brilhante et al., 2012; 
Couto et al., 2009; Nandagopal et al., 2012). These assays may require further evaluation with 
additional bacterial species such as B. mallei and B. thailandensis for it to be reliable and useful in 
clinical studies. 
 
Type three secretion system (TTSS) 
The most remarkable difference between B. pseudomallei and B. thailandensis is in their virulence. In 
order to link detection and virulence of the above two biotypes, a PCR test targeting loci within the 
type three secretion system gene cluster1 (TTSS1) was developed (Winstanley & Hart, 2000). 
Although the study was designed to identify virulence, the targeted gene may also serve as a potential 
target for B. pseudomallei detection. The test had 100% sensitivity and 93.3% (1/15) specificity. 
However, a series of follow-up evaluation studies came up with low sensitivity (Chen et al., 2002; 
Smith-Vaughan et al., 2003) and this was attributed to sample type differences in the studies, with 
purified DNA from bacterial culture having the highest sensitivity and specificity. Another novel 
TaqMan qPCR method was developed by Novak et al., (2006) which targeted orf2 within the TTS1 
and recorded 100% clinical sensitivity on blood samples. The procedure was evaluated using the same 
protocol, but different samples and recorded consistent high accuracies approaching 100% (Kaestli et 
al., 2012; Price et al., 2012; Trung et al., 2011). Therefore, Novak et al's qPCR assay is currently one 
of the best qPCR protocols available for detecting B. pseudomallei in clinical samples. 
 
Other PCR technique targeting type three secretion system gene cluster1 (TTSS1) included that of Al-
Marzooq et al., (2011) who developed a TaqMan duplex procedure that successfully detected and 
differentiated B. pseudomallei and Streptococcus pneumoniae in purified DNA and clinical sample in 
pneumonic patients. A follow-up study reported a patient sensitivity and specificity of 100% and 89.1% 
(5/46) respectively (Mustafa, Al-Marzooq, How, Kuan, & Ng, 2011). 
 
Serine metalloprotease  
Serine metalloprotease (mprA) is another virulence gene targeted in PCR methods. Two PCR 
methods were developed and evaluated for testing clinical but not environmental samples. A gel PCR 
developed by Neubauer et al., (2007) had 100% accuracy on a clinical sample from a camel and was 
later followed-up with testing purified DNA and clinical samples (Kaestli et al., 2012). However, in 
Kaestli et al’s assay, six other qPCR were compared using the same clinical samples, but Neubauer et 
al's assay had the lowest clinical accuracy. Therefore, other assays may be preferable for clinical 
detection of B. pseudomallei.  
 
In the following three years, two sets of PCR methods, a gel PCR and SYBR Green qPCR targeting 
the same gene (mprA) have been developed and evaluated for their ability to detect and differentiate B. 
pseudomallei (Suppiah, Thimma, Cheah, & Vadivelu, 2010). These PCR protocols have a potential 
diagnostic use but needfurther evaluation with additional clinical samples and their accuracy need to 
be compared to culture (gold standard) instead of immunofluorescent antibody assays that were used 
to confirm the presence of B. pseudomallei in the study. 
 
Single nucleotide polymorphisms (SNP) 
Two TaqMan duplex qPCR assays have been developed by Price et al., (2012) to differentiate B. 
pseudomallei and a complex comprising B. thailandensis, B. thailandensis- like species, and B. 
oklahomensis by targeting an SNP with sensitivity of 100% and a specificity of 98.4%. A follow-up 
tests by Kaestli et al., (2012) indicated a reduced clinical sensitivity of 68% when evaluated and 
compared with six other PCR methods.  
 
Other targeted genes 
Several PCR protocols have been developed to target different genes not discussed above. These 
genes included (but not limited to) the following: Repetitive element (Liu et al., 2002), 
polyhydroxyalkanoate synthase (phaC) gene and Aspartyl/Asparaginyl β-hydroxylase (lpxO) gene 
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(Merritt et al., 2006)Trans-Activator of Transcription (TAT) domain proteins (Ho et al., 2011), 
Transposase family protein (TFP) of TTSS 1(Zhang et al., 2012) etc. 
 
Macrogenomic analysis, genotyping and DNA fingerprinting techniques 
More sophisticated PCR-based molecular techniques have been developed for epidemiological and 
taxonomical studies of B. pseudomallei and other related species. These techniques use restriction 
enzymes to cut genomic DNA at specific sites and resolving gel electrophoresis used to visualize 
DNA fragments for size estimation and further characterization. Macrorestriction analysis, typing and 
fingerprinting techniques employed in characterizing B. pseudomallei in epidemiological studies and 
comparative genomics include Ribotyping Restriction Fragment Length Polymorphism (RFLP), 
Randomly Amplified Polymorphic DNA (RAPD) and Multi-locus Sequence Technique (MLST). 
Other non-PCR-based technique include Pulsed Field Gel Electrophoresis (PFGE). The choice of a 
technique depends on the type of study, the nature of the samples or isolate and the outcome desired. 
 
Restriction fragment length polymorphisms (RFLPs) 
This is a technique that involves ‘bar-coding’ of all or part of the genes coding 16s and 23s rRNA 
which can be used to identify the origin of a DNA (just as a barcode is used to identify a product). 
Ribotyping is the easiest epidemiological tool utilized in studying a number of bacterial pathogens, as 
patterns of restriction fragment length polymorphisms (RFLPs) in ribosomal RNA genes from 
different isolates are compared. 
 
Using ribotyping, B. pseudomallei from a number of sources was classified into 22 ribotypes (Lew 
and Desmarchelier, 1994). Trakulsomboon et al., (1997) used the same technique and investigated the 
differences between clinical and environmental strains of B. pseudomallei with results indicating the 
ribotype patterns falling into two groups which were later clearly identified as B. pseudomallei 
isolates (Ribotype I) and B. thailandensis isolates (Ribotype II). Through Ribotyping, Pitt et al., (2000) 
discovered that certain ribotypes are the most common and prevalent worldwide. Though RFLP 
analysis was the first inexpensive and widespread DNA profiling technique, it has now become an 
obsolete technique due to the availability of inexpensive DNA sequencing technologies.  
 
Randomly amplified polymorphic DNA (RAPD) 
When properly optimized, RAPD PCR can be used as a tool in population studies, phylogenetic 
analysis, gene mapping, and molecular typing of various microorganisms (Welch and McClelland, 
1990; Williams et al., 1990). Few studies were documented using RAPD PCR techniques in studying 
the epidemiology of B. pseudomallei because of its limitation of experimental irreproducibility. The 
work of Haase et al., (1995) demonstrated the use of RAPD PCR in detecting recurrent infection of B. 
pseudomallei and using the same protocol in typing B. pseudomallei in separate epidemiological 
studies. Leelayuwat et al., (2000) utilized a RAPD PCR technique in typing B. pseudomallei and the 
results of RAPD patterns obtained were indicative of genetic variations between non-virulent and 
virulent clinical isolates. 
 
Multilocus sequence typing (MLST) 
This has been one of the advanced molecular and unique typing techniques that focussed on the 
differences in the nucleotide sequence data of some selected housekeeping genes between isolates. 
MLST has become one of the reliable advanced techniques used in the characterization of many 
bacterial isolates (especially for epidemiological purposes) including B. pseudomallei (Chen et al., 
2013; Nandi et al., 2010; Sim et al., 2008). It is widely and increasingly being used nowadays because 
its advantage of inter-laboratory comparisons. MLST technique indexes variations at seven core 
housekeeping genes. The nucleotide sequences generated after the technique are routinely compared 
between nucleotide sequences deposited on an internet-based database (http://www.mlst.net/) by 
various laboratories around the globe. This database holds the nucleotide sequence profiles of all the 
housekeeping genes previously characterised and deposited into it for comparative purposes.  
 
Nowadays, MLST database systems have been developed and described for many bacterial pathogens 
such as Staphylococcus aureus (Enright, Day, Davies, Peacock, & Spratt, 2000), Neisseria 
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meningitides (Maiden et al., 1998), Streptococcus pneumonia (Enright & Spratt, 1998), B. 
pseudomallei (Godoy et al., 2003) and etc. B. pseudomallei MLST sequence database has been 
developed and consists of seven housekeeping genes of close to two thousand B. pseudomallei strains 
that have been sequenced and deposited by various laboratories around the globe (Godoy et al., 2003). 
 
In Taiwan, Chen et al., (2013) a study showed evidence that distinct MLST types of B. pseudomallei 
were clustered in Er-Ren River Basin axis. This supported the earlier contention that riverside area of 
Er-Ren is among the highest risk area for melioidosis in Taiwan. Recently, a study in Malaysian 
Borneo by Podin et al., (2014) identified some clinical isolates of B. pseudomallei in a certain MLST 
type with surprising sensitivity to aminoglycoside and macrolide antibiotics. These isolates were 
traced and found to belong to a vast area within regions in Sarawak. Using whole-genome sequencing 
(WGS) of the isolates, they identified a nonsynonymous mutation within the AmrAB-OprA (a 
multidrug efflux pump) which is confirmed by restoration of aminoglycoside and macrolide resistance 
by simply a reversion of this mutation. 
 
Pulsed-field gel electrophoresis (PFGE) technique 
This is one of the most widely used DNA macrorestriction analyses that are capable of discriminating 
the various phenotypically identical isolates, and also of proving genetic relatedness and indicating 
probable clonality of strains that are ‘identical’ in their phenotypical and biochemical properties. The 
technique may also be used to clarify which genotype is associated with certain geographical location 
(Vadivelu, et al., 1997). PFGE typing technique has been shown to be reproducible and highly 
discriminatory for epidemiological study of B. pseudomallei (Chen et al., 2013; Chua et al., 2011; 
Chua et al., 2010; Pitt et al., 2000; Koonpaew et al., 2000).  
 
Conclusions  
B. pseudomallei and B. mallei cause serious diseases with high mortality rates. Their persistence in 
the environment, virulence, low infectious dose, fear to be used as a bioweapon necessitates the need 
for rapid and accurate detection methods. Developing assays that reduce the diagnostic time could 
decrease morbidity and mortality rates of the diseases in endemic areas. Similarly, close phenotypic 
and genotypic similarities of the species within the genus Burkholderia which resulted in 
misidentification has led to the development of molecular techniques that sufficiently discriminate the 
species for accurate identification in clinical and environmental studies.  
 
The future of diagnostic testing is constantly shifting towards a molecular approach. However, these 
techniques are not accessible to most communities in developing and underdeveloped countries. This 
is because development and conducting these assays depend heavily on the facilities, the presence of 
trained personnel, funding, and difficult to implement due to the high degree of optimization that is 
required. 
 
Secondly, most of these techniques restrict detection and differentiation to a single target. This is due 
to the fact that most PCR-based assays are designed around a well-conserved gene or genes. These 
gene(s) may spontaneously mutate (especially in newly emerging strains) which can then compromise 
the tests. Beside possible gene mutations, other limitations include false positive cases reported due 
high sensitivity of some PCR-based assays, false negatives, sample types and processing. These 
limitations can decrease the overall throughput of the entire PCR/qPCR process. 
 
These limitations can be overcome by developing multiplex procedures by performing a certain 
molecular technique and affirming with another. An example is by combining MLST and PFGE 
together as seen in the study of Podin et al., (2014). The generation of online databases containing 
annotated genomes of Burkholderia species (due to increasing affordability of sequencing 
technologies) may help to identify variations or mutations within a conserved gene and therefore pave 
way towards developing better assays, by facilitating the development of degenerate primers. The 
versatility of qPCR internal probes helps to resolve some of the limitations previously described 
which confer additional layer of specificity compared to methods that use only primers.  
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It is important to stress that, most of the methods being evaluated in clinical and environmental 
situations display appreciable high sensitivity and specificity. However, a recommendation on which 
method to be adopted can only be made after a thorough and careful consideration of the nature of the 
intended study. This is because most of the existing studies are unable to specifically detect and 
differentiate all species of the B. pseudomallei complex. Therefore, the usefulness of a specific test is 
dependent on the user's needs 
 
PCR-based methodologies alone, with currently established procedures, cannot be used with 100% 
confidence. Therefore, it is recommended that B. pseudomallei complex PCR-based assays should be 
complimented with culture and/ or additional tests until more research proves otherwise. Although 
disadvantages of PCR-based methods exist, alternative detection methods have their own 
disadvantages in that they are usually slower and less accurate. These factors may contribute to the 
high mortality rates of melioidosis in poorer endemic regions (especially rice-paddy communities in 
remote areas that may not have access to these resources). 
 
For single/dual-gene molecular study, it is evident from the above review that for laboratory 
confirmation of presumptive B. pseudomallei isolates alone, a 16s rRNA gene sequencing technique is 
sufficient and therefore recommended molecular diagnostic and confirmatory tool in cases of 
melioidosis. Similarly, in macrogenomic analysis and DNA Fingerprinting techniques employed in 
epidemiological studies, MLST is the best and more preferable nowadays because of its advantage 
over PFGE technique of inter-laboratory comparisons of nucleotide sequences generated by an online 
database that hold MLST sequences types of more than 1000 sequences of pseudomallei strains 
deposited (http: //www.mlst.net/). 
 
References 
Al-Marzooq, F., Imad, M. A., How, S. H., & Kuan, Y. C. (2011). Development of multiplex real-time 
PCR for the rapid detection of five bacterial causes of community acquired pneumonia. Tropical 
Biomedicine, 28(3), 545–556. 
Antonov, V. A., Tkachenko, G. A., Altukhova, V. V, Zamaraev, V. S., Iliukhin, V. I., & Trofimov, D. 
I. (2004). Use of PCR for identification of Burkholderia mallei. Molekuliarnaia Genetika, 
Mikrobiologiia I Virusologiia, 1, 12–17. 
Ashdown, L. R. (1979). Identification of Pseudomonas pseudomallei in the clinical laboratory. 
Journal of Clinical Pathology, 32(5), 500–504. 
Brett, P., & Woods, D. (2000). Pathogenesis of and immunity to melioidosis. Acta Tropica, 74(2-3), 
201–210. 
Brilhante, R. S. N., Bandeira, T. J. P. G., Cordeiro, R. A., Grangeiro, T. B., Lima, R. A. C., Ribeiro, J. 
F., … Sidrim, J. J. C. (2012). Clinical-epidemiological features of 13 cases of melioidosis in 
Brazil. Journal of Clinical Microbiology, 50(10), 3349–3352. 
Brook, M. D., Currie, B., & Desmarchelier, P. M. (1997). Isolation and identification of Burkholderia 
pseudomallei from soil using selective culture techniques and the polymerase chain reaction. 
Journal of Applied Microbiology, 82(5), 589–596. 
Burkholder, W. H. (1950). Sour skin, a bacterial rot of onion bulbs. Phytopathology, 40(1), 115–118. 
Chantratita, N., Wuthiekanun, V., Limmathurotsakul, D., Thanwisai, A., Chantratita, W., Day, N. P. J., 
& Peacock, S. J. (2007). Prospective clinical evaluation of the accuracy of 16S rRNA real-time 
PCR assay for the diagnosis of melioidosis. The American Journal of Tropical Medicine and 
Hygiene, 77(5), 814–817. 
Chen, Y., Lin, H., Pan, N., Chien, S., & Chen, Y. (2002). Comparison of 16S RNA, flagella and type 
III secretion gene PCR primer sets for diagnosis of Ara- Burkholderia pseudomallei in paddy 
soil. Journal of Biomedical Laboratory Science, 14, 95–100. 
Chen, Y.-L., Lin, Y.-C., Chen, Y.-S., Chen, S.-C., Liu, Y.-M., Tseng, I.-L., … Mu, J.-J. (2013). 
PJSRR (2016) 2(2): 69-79 
eISSN: 2462-2028 © Universiti Putra Malaysia Press 
 
76 
 
Characterisation of predominant molecular patterns of Burkholderia pseudomallei in Taiwan. 
Transactions of the Royal Society of Tropical Medicine and Hygiene, 107(3), 165–169. 
Chen, Y.-S., Lin, H.-H., Mu, J.-J., Chiang, C.-S., Chen, C.-H., Buu, L.-M., … Chen, Y.-L. (2010). 
Distribution of melioidosis cases and viable Burkholderia pseudomallei in soil: evidence for 
emerging melioidosis in Taiwan. Journal of Clinical Microbiology, 48(4), 1432–1434. 
Chua, K. H., See, K. H., Thong, K. L., & Puthucheary, S. D. (2010). DNA fingerprinting of human 
isolates of Burkholderia pseudomallei from different geographical regions of Malaysia. Tropical 
Biomedicine, 27(3), 517–524. 
Chua, K. H., See, K. H., Thong, K. L., & Puthucheary, S. D. (2011). SpeI restriction enzyme displays 
greater discriminatory power than XbaI enzyme does in a pulsed-field gel electrophoresis study 
on 146 clinical Burkholderia pseudomallei isolates. Japanese Journal of Infectious Diseases, 
64(3), 228–233. 
Couto, M. S., Cordeiro, R. de A., Rocha, M. F. G., Grangeiro, T. B., Leitão Junior, N. P., Bandeira, T. 
de J. P. G., … Brilhante, R. S. N. (2009). A diagnosis of Burkholderia pseudomallei directly in a 
bronchoalveolar lavage by polymerase chain reaction. Diagnostic Microbiology and Infectious 
Disease, 65(1), 73–75. 
Dharakul, T., Songsivilai, S., Viriyachitra, S., Luangwedchakarn, V., Tassaneetritap, B., & 
Chaowagul, W. (1996). Detection of Burkholderia pseudomallei DNA in patients with 
septicemic melioidosis. Journal of Clinical Microbiology, 34(3), 609–614. 
Dharakul, T., Tassaneetrithep, B., & Trakulsomboon, S. (1999). Phylogenetic Analysis of Ara + and 
Ara − Burkholderia pseudomallei isolates and development of a multiplex PCR procedure for 
rapid discrimination between the two biotypes. Journal of Clinical Microbiology, 37(6), 1906–
1912. 
Enright, M. C., Day, N. P. J., Davies, C. E., Peacock, S. J., & Spratt, B. G. (2000). Multilocus 
sequence typing for the characterization of methicillin- resistant (MRSA) and methicillin-
susceptible (MSSA) clones of Staphylococcus aureus. Journal of Clinical Microbiology, 38, 
1008–1015. 
Enright, M. C., & Spratt, B. G. (1998). A multilocus sequence typing scheme for Streptococcus 
pneumoniae: identification of clones associated with serious invasive disease. Microbiology, 144, 
3049–3060. 
Gilad, J., Harary, I., Dushnitsky, T., Schwartz, D., & Amsalem, Y. (2007). Burkholderia mallei and 
Burkholderia pseudomallei as bioterrorism agents: national aspects of emergency preparedness. 
The Israel Medical Association Journal, 9(7), 499–503. 
Godoy, D., Randle, G., Simpson, A. J., Aanensen, M., Pitt, T. L., Kinoshita, R., … Spratt, B. G. 
(2003). Multilocus sequence typing and evolutionary relationships among the causative agents 
of melioidosis and glanders, Burkholderia pseudomallei and Burkholderia mallei. Journal of 
Clinical Microbiology, 41(5), 2068–2079. 
Haase, A., Brennan, M., Barrett, S., Wood, Y., Huffam, S., O’Brien, D., & Currie, B. (1998). 
Evaluation of PCR for diagnosis of melioidosis. Journal of Clinical Microbiology, 36(4), 1039–
1041. 
Haase, A., Melder, A., Smith-Vaughan, H., Kemp, D., & Currie, B. (1995). RAPD analysis of isolates 
of Burkholderia pseudomallei from patients with recurrent melioidosis. Epidemiology and 
Infections, 115(1), 115–121. 
Hagen, R. M., Gauthier, Y. P., Sprague, L. D., Vidal, D. R., Zysk, G., Finke, E.-J., & Neubauer, H. 
(2002). Strategies for PCR based detection of Burkholderia pseudomallei DNA in paraffin wax 
embedded tissues. Molecular Pathology, 55(6), 398–400. 
Haynes, W. C. (1957). Bergey’s Manual of Determinative Bacteriology (7th ed.). Baltimore: Williams 
& Williams. 
Ho, C.-C., Lau, C. C. Y., Martelli, P., Chan, S.-Y., Tse, C. W. S., Wu, A. K. L., … Woo, P. C. Y. 
PJSRR (2016) 2(2): 69-79 
eISSN: 2462-2028 © Universiti Putra Malaysia Press 
 
77 
 
(2011). Novel pan-genomic analysis approach in target selection for multiplex PCR 
identification and detection of Burkholderia pseudomallei, Burkholderia thailandensis, and 
Burkholderia cepacia complex species: a proof-of-concept study. Journal of Clinical 
Microbiology, 49(3), 814–821. 
Inglis, T., Merritt, A., Chidlow, G., Aravena-Roman, M., & Harnett, G. (2005). Comparison of 
diagnostic laboratory methods for identification of Burkholderia pseudomallei. Journal of 
Clinical Microbiology, 43(5), 2201–2206. 
Kaestli, M., Richardson, L. J., Colman, R. E., Tuanyok, A., Price, E. P., Bowers, J. R., … Currie, B. J. 
(2012). Comparison of TaqMan PCR assays for detection of the melioidosis agent Burkholderia 
pseudomallei in clinical specimens. Journal of Clinical Microbiology, 50(6), 2059–2062. 
Kao, C. M., Chen, S. C., Chen, Y. S., Lin, H. M., & Chen, Y. L. (2003). Detection of Burkholderia 
pseudomallei in rice fields with PCR-based technique. Folia Microbiology, 48(4), 521–524. 
Koonpaew, S., Ubol, M. N., Sirisinha, S., White, N. J., & Chaiyaroj, S. C. (2000). Genome 
fingerprinting by pulsed-field gel electrophoresis of isolates of Burkholderia pseudomallei from 
patients with melioidosis in Thailand. Acta Tropica, 74(2-3), 187–191. 
Kunakorn, M., & Markham, R. B. (1995). Clinically practical seminested PCR for Burkholderia 
pseudomallei quantitated by enzyme immunoassay with and without solution hybridization. 
Journal of Clinical Microbiology, 33(8), 2131–2135. 
Kunakorn, M., Raksakait, K., Sethaudom, C., Sermswan, R. W., & Dharakul, T. (2000). Comparison 
of three PCR primer sets for diagnosis of septicemic melioidosis. Acta Tropica, 74(2-3), 247–
251. 
Lazar Adler, N. R., Govan, B., Cullinane, M., Harper, M., Adler, B., & Boyce, J. D. (2009). The 
molecular and cellular basis of pathogenesis in melioidosis: how does Burkholderia 
pseudomallei cause disease? FEMS Microbiology Reviews, 33(6), 1079–1099. 
http://doi.org/10.1111/j.1574-6976.2009.00189.x 
Leelayuwat, C., Romphruk, A., Lulitanond, A., Trakulsomboon, S., & Thamlikitkul, V. (2000). 
Genotype analysis of Burkholderia pseudomallei using randomly amplified polymorphic DNA 
(RAPD): indicative of genetic differences amongst environmental and clinical isolates. Acta 
Tropica, 77(2), 229–237. 
Lew, A.E., and Desmarchelier, P. M. (1994). Detection of Pseudomonas pseudomallei by PCR and 
hybridization. Journal of Clinical Microbiology, 32, 1326–1332. 
Li, X., & Hayward, A. C. (1994). Bacterial whole cell protein profiles of the rRNA group 11 
pseudomonads. Journal of Applied Bacteriology, 77(3), 308–318. 
Liu, Y., Wang, D., Ã, E. U. H. Y. A. P., Yap, E. P. H., & Lee, M. (2002). Identification of a novel 
repetitive DNA element and its use as a molecular marker for strain typing and discrimination of 
ara- from ara+ Burkholderia pseudomallei isolates. Journal of Medical Microbiology, 51(1), 76–
82. 
Maiden, M. C. J., Bygraves, J. A., Feil, E. J., Morelli, G., Russell, J. E., Urwin, R., … B.G., S. (1998). 
Multilocus sequence typing: a portable approach to the identification of clon. Proceedings of the 
National Academy of Sciences of the United States of America, 95, 3140–3145. 
Merritt, A., Inglis, T. J. J., Chidlow, G., & Harnett, G. (2006). PCR-Based Identification of 
Burkholderia pseudomallei. Revista Do Instituto de Medicina Tropical de São Paulo, 48(5), 
239–244. 
Mustafa, M. I., Al-Marzooq, F., How, S. H., Kuan, Y. C., & Ng, T. H. (2011). The use of multiplex 
real-time PCR improves the detection of the bacterial etiology of community acquired 
pneumonia. Tropical Biomedicine, 28(3), 531–544. 
Nandagopal, B., Sankar, S., Lingesan, K., Appu, K., Sridharan, G., & Gopinathan, A. (2012). 
Application of polymerase chain reaction to detect Burkholderia pseudomallei and Brucella 
species in buffy coat from patients with febrile illness among rural and peri-urban population. 
PJSRR (2016) 2(2): 69-79 
eISSN: 2462-2028 © Universiti Putra Malaysia Press 
 
78 
 
Journal of Global Infectious Diseases, 4(1), 31–37. 
Nandi, T., Ong, C., Singh, A. P., Boddey, J., Atkins, T., Sarkar-Tyson, M., … Tan, P. (2010). A 
genomic survey of positive selection in Burkholderia pseudomallei provides insights into the 
evolution of accidental virulence. PLoS Pathogens, 6(4), e1000845. 
Neubauer, H., Sprague, L. D., Joseph, M., Tomaso, H., Dahouk, S. Al, Witte, A., … Scholz, H. C. 
(2007). Development and Clinical Evaluation of A PCR Assay Targeting the Metalloprotease 
Gene (mprA) of B. pseudomallei. Zoonosis and Public Health, 54(1), 44–50. 
Novak, R. T., Glass, M. B., Gee, J. E., Gal, D., Mayo, M. J., Currie, B. J., & Wilkins, P. P. (2006). 
Development and evaluation of a real-time PCR assay targeting the type III secretion system of 
Burkholderia pseudomallei. Journal of Clinical Microbiology, 44(1), 85–90. 
Pitt, T. L., Trakulsomboon, S., & Dance, D. A. B. (2000). Molecular phylogeny of Burkholderia 
pseudomallei. Acta Tropica, 74(2-3), 181–185. 
Podin, Y., Sarovich, D. S., Price, E. P., Kaestli, M., Mayo, M., Hii, K., … Currie, B. J. (2014). 
Burkholderia pseudomallei isolates from Sarawak, Malaysian Borneo, are predominantly 
susceptible to aminoglycosides and macrolides. Antimicrobial Agents and Chemotherapy, 58(1), 
162–166. 
Price, E. P., Dale, J. L., Cook, J. M., Sarovich, D. S., Seymour, M. L., Ginther, J. L., … Pearson, T. 
(2012). Development and validation of Burkholderia pseudomallei-specific real-time PCR 
assays for clinical, environmental or forensic detection applications. PloS One, 7(5), e37723. 
Rattanathongkom, A., Sermswan, R. W., & Wongratanacheewin, S. (1997). Detection of 
Burkholderia pseudomallei in blood samples using polymerase chain reaction. Molecular and 
Cellular Probes, 11(1), 25–31. 
Sim, S. H., Yu, Y., Lin, C. H., Karuturi, R. K. M., Wuthiekanun, V., Tuanyok, A., … Tan, P. (2008). 
The core and accessory genomes of Burkholderia pseudomallei: implications for human 
melioidosis. PLoS Pathogens, 4(10), e1000178. 
Smith-Vaughan, H. C., Gal, D., Lawrie, P. M., Winstanley, C., Sriprakash, K. S., & Currie, B. J. 
(2003). Ubiquity of putative type III secretion genes among clinical and environmental 
Burkholderia pseudomallei isolates in Northern Australia. Journal of Clinical Microbiology, 
41(2), 883–885. 
Sonthayanon, P., Krasao, P., Wuthiekanun, V., Panyim, S., & Tungpradabkul, S. (2002). A simple 
method to detect and differentiate Burkholderia pseudomallei and Burkholderia thailandensis 
using specific flagellin gene primers. Molecular and Cellular Probes, 16(3), 217–222. 
Suppiah, J., Thimma, J. S., Cheah, S. H., & Vadivelu, J. (2010). Development and evaluation of 
polymerase chain reaction assay to detect Burkholderia genus and to differentiate the species in 
clinical specimens. FEMS Microbiology Letters, 306(1), 9–14. 
Tkachenko, G. A., Antonov, V. A., Zamaraev, V. S., & Iliukhin, V. I. (2003). Identification of the 
causative agents of glanders and melioidosis by polymerase chain reaction. Molekuliarnaia 
Genetika, Mikrobiologiia I Virusologiia, 3, 18–22. 
Tomaso, H., Pitt, T. L., Landt, O., Al Dahouk, S., Scholz, H. C., Reisinger, E. C., … Neubauer, H. 
(2005). Rapid presumptive identification of Burkholderia pseudomallei with real-time PCR 
assays using fluorescent hybridization probes. Molecular and Cellular Probes, 19(1), 9–20. 
Tomaso, H., Scholz, H. C., Al Dahouk, S., Pitt, T. L., Treu, T. M., & Neubauer, H. (2004). 
Development of 5’ nuclease real-time PCR assays for the rapid identification of the 
Burkholderia mallei/Burkholderia pseudomallei complex. Diagnostic Molecular Pathology, 
13(4), 247–253. 
Trakulsomboon, S., Dance, D. A., Smith, M. D., White, N. J., & Pitt, J. L. (1997). Ribotype 
differences between clinical and environmental isolates of B. pseudomallei. Journal of Medical 
Microbiology, 46(7), 565–570. 
PJSRR (2016) 2(2): 69-79 
eISSN: 2462-2028 © Universiti Putra Malaysia Press 
 
79 
 
Trung, T. T., Hetzer, A., Göhler, A., Topfstedt, E., Wuthiekanun, V., Limmathurotsakul, D., … 
Steinmetz, I. (2011). Highly sensitive direct detection and quantification of Burkholderia 
pseudomallei bacteria in environmental soil samples by using real-time PCR. Applied and 
Environmental Microbiology, 77(18), 6486–6494. 
Tyler, S. D., Strathdee, C. A., & Rozee, K. R. (1995). Oligonucleotide Primers Designed To 
Differentiate Pathogenic Pseudomonads on the Basis of the Sequencing of Genes Coding for 
16S-23S rRNA Internal Transcribed Spacers. Clinical and Diagnostic Laboratory Immunology, 
2(4), 448–453. 
Vadivelu, J., Puthucheary, S. D., Mifsud, A., Drasar, B. S., Dance, D. A., & Pitt, T. I. (1997). 
Ribotyping and DNA macrorestriction analysis of isolates of Burkholderia pseudomallei from 
cases of melioidosis in Malaysia. Transactions of the Royal Society of Tropical Medicine and 
Hygiene, 91(3), 358–360. 
Wajanarogana, S., Sonthayanon, P., Simpson, A. J. H., Tungpradabkul, S., & Panyini, S. (1999). 
Stable marker on flagellin gene sequences to arabinose non-assimilating pathogenic 
Burkholderia pseudomallei. Microbiology and Immunology, 43(11), 995–1001. 
Welch, J., & McClelland, M. (1990). Fingerprinting genomes using PCR with Arbitary Primers. 
Nucleic Acids Reviews, 18(24), 7213–7218. 
Williams, J. G. K., Kubelik, A. R., Livak, K. J., Rafalski, J. A., & Tingly, S. V. (1990). DNA 
polymorphisms amplified by arbitary primers are useful as genetic markers. Nucleic Acids 
Reviews, 18(22), 6531–6535. 
Winstanley, C., & Hart, C. A. (2000). Presence of type III secretion genes in Burkholderia 
pseudomallei correlates with ara + phenotypes. Journal of Clinical Microbiology, 38(2), 883–
885. 
Yabuuchi, E., Kosako, Y., Oyaizu, H., Yano, I., Hotta, H., Hashimoto, Y., … Arakawa, M. (1992). 
Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas 
homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and 
Holmes 1981) comb. nov. Microbiology and Immunology, 36(12), 1251–1275. 
Yap, E. P. H., Ang, S. M., Seah, S. G. K., & Phang, S. M. (2002). Homogeneous assays for the rapid 
PCR detection of Burkholderia pseudomallei 16S rRNA gene on a real- time fluorometric 
capillary thermocycler. In Rapid Cycle Real Time PCR - Methods and Application. In 
Microbiology and Food Analysis (pp. 59–67). (Berlin, Springer). 
Zhang, B., Wear, D. J., Kim, H. S., Weina, P., Stojadinovic, A., & Izadjoo, M. (2012). Development 
of hydrolysis probe-based real-time PCR for identification of virulent gene targets of 
Burkholderia pseudomallei and B. mallei: A retrospective study on archival cases of service 
members with melioidosis and glanders. Military Medicine, 177(2), 216–221. 
 
 
 
